Study periods | Screening | Baseline assessment (T0) | Treatment, intervention period | Post-intervention assessment (T1) | Follow-up (T2) | |||
---|---|---|---|---|---|---|---|---|
Time (week) | −3 to −1 | 0 | 1 | 2 | 3 | 4 | 5 | 15 w after discharge |
Patient information and informed consent | x | Â | Â | Â | Â | Â | Â | Â |
Demographics | x | Â | Â | Â | Â | Â | Â | Â |
Medical history | x | Â | Â | Â | Â | Â | Â | Â |
Inclusion/exclusion criteria | x | Â | Â | Â | Â | Â | Â | Â |
Allocation (after T0) | Â | x | Â | Â | Â | Â | Â | Â |
Gait training (Intervention) | Â | Â | x | x | x | x | Â | Â |
Walking speed (2-min Walk Test) | Â | x | Â | Â | Â | Â | x | Â |
Balance (BBS) | Â | x | Â | Â | Â | Â | x | Â |
Gait parameters | Â | Â | x | x | x | x | Â | Â |
Compliance and motivation (questionnaire) | Â | Â | Â | x | Â | x | Â | Â |
Fear of falling (FES) | Â | Â | Â | Â | Â | Â | x | x |
Falls Diary | Â | Â | Â | Â | Â | Â | Â | x |
Quality of life SF-36 | Â | Â | Â | Â | Â | Â | Â | x |
Concomitant therapy (usual care for inpatients) | x | x | x | x | x | x | x | Â |
Adverse events | Â | x | x | x | x | x | x | Â |